Navigation Links
Heifer and Elanco Announce Charitable Partnership
Date:7/29/2008

LITTLE ROCK, Ark., July 29 /PRNewswire/ -- Heifer International and Elanco today announced that they have signed a corporate partnership agreement. Heifer International is a world hunger organization. Elanco is an animal health company headquartered in Greenfield, Indiana, that has offices in 30 countries around the world. Elanco makes veterinary medicines and products to improve animal health and productivity.

The partnership will engage the unique talents of Elanco's employees in the causes of hunger and poverty around the world through education, contribution, and participation in activities beneficial to Heifer International.

Elanco (http://www.elanco.com) is a global research-based company with more than 2,000 employees committed to improving the health and productivity of animals in more than 100 countries. Elanco is a division of Eli Lilly and Company, a leading, innovation-driven pharmaceutical corporation committed to helping people live longer, healthier and more active lives. Elanco's products enhance animal health, wellness and productivity to help the food industry produce an abundant supply of safe and affordable food, and to help pets live longer, healthier, happier lives. Elanco is committed to developing products that are safe for animals, the environment and consumers.

Elanco seeks solutions to control disease and enhance the production efficiency of all food-producing animals as well as therapeutic agents for managing acute and chronic diseases and parasites in companion animals.

Heifer and Elanco issued a joint mission statement for their cooperative agreement:

"How animals are raised is fundamental to the work of ending hunger and poverty around the world. Healthy animals help create healthy livelihoods, healthy communities, healthy futures. The coming together of Heifer International and Elanco helps complete the circle of possibility for hungry people everywhere; a shared commitment to providing trusted solutions -- for animals and people alike."

Heifer's mission is to end hunger and poverty while caring for the earth. For more than 60 years, Heifer International has provided livestock and environmentally sound agricultural training to improve the lives of those who struggle daily for reliable sources of food and income. Heifer is currently working in more than 57 countries, including the U.S., to help families and communities become more self-reliant. Since 1944 it has helped 48 million people through training in livestock development and livestock gifts that multiply. Every gift of an animal provides direct benefits such as milk, eggs, wool, fertilizer, and indirect benefits that increase family incomes for better housing, nutrition, health care and school fees for children. Recipients "Pass on the Gift" of offspring of their cows, goats and other livestock to others in an ever-widening circle of hope. In addition to Elanco, Heifer International has corporate partnerships with the American Veterinary Medicine Association, Dr. Hauschka Skin Care, Green Mountain Coffee Roasters, Organic Valley of Family Farms and Scholastic.

For further information about Heifer, visit http://www.heifer.org, or call 1-800-696-1918.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Ray White http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=76382 Terry Wollen http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=76389


'/>"/>
SOURCE Heifer International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Align Technology Announces Second Quarter Fiscal 2008 Results
2. Monogram Announces 2008 Second Quarter Financial Results
3. Webcast Alert: Medial Saude S/A Announces Second Quarter 2008 Earnings Conference Call Webcast
4. The Quantum Group Announces Exclusive Screening of New PWeR(TM) System
5. Burgess Announces Expanded Software Partnership With Health Net
6. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
7. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
8. Genomic Health to Announce Second Quarter 2008 Financial Results and Host Conference Call on Tuesday, August 5, 2008
9. Fast Radios Announces Publication of Two Way Radio Guide for Commercial Customers
10. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
11. CVT Announces That FDA Continues to Review Ranexa(R) Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... 23, 2017 , ... The Pharmacy and Medically Underserved Areas ... original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. The Senate ... Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for their leadership ...
(Date:1/24/2017)... Ariz. (PRWEB) , ... January 23, 2017 , ... ... recently analyzed statistics from 140 Buzzies users who entered metrics into the product’s ... earlier clinical data. The new data showed that within just 30 seconds of ...
(Date:1/23/2017)... ... , ... PKF O’Connor Davies , LLP, the nation’s 26th largest accounting ... Firm, will participate in the 40th Annual "Empire State Building Run Up" on Feb. ... steps, a vertical distance equal to about a fifth of a mile, to reach ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have been ... and improve balance. Kumo Board is the first and only balance board to ... to be soft and rigid at the same time as well as skill-level adjustable for ...
(Date:1/23/2017)... ... 23, 2017 , ... METTLER TOLEDO has announced the availability ... Simple PAT Tools . , Crystallization is a common step used ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... -- The global peripheral I.V. catheter market accounted for ... to grow at a CAGR of 6.0% during 2016-2022. ... share in the global market between the two types ... hospital segment accounted for the highest share in the ... I.V. catheter market is witnessing high growth rate, due ...
(Date:1/23/2017)... , Jan. 23, 2017  HOPE BIOSCIENCES ... rights to develop and commercialize nuc -gemcitabine™ ... a Korean pharmaceutical company. nuc ... aptamer against surface nucleolin found on many cancer ... Unlike ADCs (antibody drug conjugates) or SMDCs (small ...
(Date:1/23/2017)... 23, 2017  Based on its recent analysis ... recognizes Ansell, a global leader in protection solutions, ... of the Year Award. Ansell,s comprehensive product portfolio, ... global footprint have placed it in a position ... The Company,s established product line and robust innovation ...
Breaking Medicine Technology: